Substance Use Disorders Edition 2

Name: Substance Use Disorders Edition 2
Brand: AAFP

Online CME

Substance Use Disorder on three device screens

15.75 AAFP
Prescribed Credits

Access Through
March 19, 2027

This free-for-members CME meets the DEA-mandated eight hours of Medication Access and Training Expansion (MATE) Act. Read more about MATE: New DEA training requirement: who has to do it, and how to get it done.

More than 48 million Americans struggle with substance use disorder, and three out of every four do not receive the treatment they need.* Chances are, a portion of your patient base needs your help.

Learn the most up-to-date practices that help create a non-stigmatizing, trauma-informed approach to treatment and recovery. Put your learning to the test with new immersive technology that simulates a real patient interaction.

You’ll explore:

Motivational interviewing skills
Evidence-based principles that help you evaluate and treat patients with SUDs
Patient-centered approaches with a focus on destigmatizing language
Harm-reduction philosophy to caring for patients and communities

*National Survey on Drug Use and Health, November 2023

AAFP Member: FREE

New Physician: FREE
Student or Resident: FREE
Other Health Care Professional: $635
Nonmember: $495

Sessions With Speakers

Alcohol Use Disorder: Screen, Diagnose, Treat and Support
Joyce Troxler, M.D.

Considering the Patient Perspective
Elizabeth Salisbury-Afshar, M.D., M.P.H., FAAFP, DFASAM, FACPM; Brandon George

Emerging Psychoactive Substances: Fentanyls, Kratom and Xylazine
Jasleen Salwan, M.D., M.P.H.

Harm Reduction and Addressing Stigma
Elizabeth Salisbury-Afshar, M.D., M.P.H., FAAFP, DFASAM, FACPM

Harm Reduction: Any Positive Change
Elizabeth Salisbury-Afshar, M.D., M.P.H., FAAFP, DFASAM, FACPM

Intake Assessment and Care Coordination
David O’Gurek, M.D.

Interpretation of Toxicology Results
Anika Alvanzo, M.D., M.S., DFASAM, FACP

Managing Common Comorbidities: Sleep, Anxiety and Depression
Sky Lee, M.D., AAHIVS

Principles of Motivational Interviewing
David O’Gurek, M.D.

Smoking Cessation and e-Cigarettes
Marie-Elizabeth Ramas, M.D., FAAFP

Stimulant Use Disorder: The Tools in Our Toolbox
Hannah Snyder, M.D.

Substance Use Disorders Edition 2 Reflection and Translation to Practice^®(t2p^®)
David O’Gurek, M.D.

The Evidence Base for Treatment of OUD
Elizabeth Salisbury-Afshar, M.D., M.P.H., FAAFP, DFASAM, FACPM

The Impact of Drug Policy on SUDs
Elizabeth Salisbury-Afshar, M.D., M.P.H., FAAFP, DFASAM, FACPM; David O’Gurek, M.D.; Jason Glenn, Ph.D.

Trauma-informed Care
David O’Gurek, M.D.

Treatment of OUD with Buprenorphine Part 1: Initiation of Treatment
Nicole Gastala, M.D.

Treatment of OUD With Buprenorphine Part 2: Follow-up Visits and Maintenance
Margaret Lowenstein, M.D., M.Phil., M.S.H.P.

What Is Addiction?
Elizabeth Salisbury-Afshar, M.D., M.P.H., FAAFP, DFASAM, FACPM

*Enhance your patient care today and earn up to 2 additional AAFP Prescribed credits for when you complete the Translation to Practice^®(t2p^®) process.

Speakers

David O’Gurek, M.D. — Course Director

Speakers:

Anika Alvanzo, M.D., M.S., DFASAM, FACP
Brandon George
David O’Gurek, M.D. — Course Director
Elizabeth Salisbury-Afshar, M.D., M.P.H., FAAFP, DFASAM, FACPM
Hannah Snyder, M.D.
Jasleen Salwan, M.D., M.P.H.
Jason Glenn, Ph.D.
Joyce Troxler, M.D.
Margaret Lowenstein, M.D., M.Phil., MSHP
Marie-Elizabeth Ramas, M.D., FAAFP
Nicole Gastala, M.D.
Sky Lee, M.D., AAHIVS

Learning Objectives

Upon completion of this CME activity, you should be able to:

Implement evidence-based guidelines and principles into the evaluation and treatment of patients with substance use disorders.
Demonstrate a patient-centered approach to the care of patients with substance use disorder with attention to destigmatizing language.
Discuss harm-reduction philosophy and approach to caring for patients and communities.
Demonstrate skills and techniques that are appropriate for use in patients with other substance use disorders.

System Requirements

CME Credit Statement

The AAFP has reviewed Substance Use Disorders Edition 2 and deemed it acceptable for up to 15.75 Enduring Materials, Self-Study AAFP Prescribed credit. Term of Approval is from 3/19/2024 to 3/19/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Academy of Family Physicians designates this Enduring Materials for a maximum of 15.75 AMA PRA Category 1 Credits^™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.

Following this CME activity, participants will have the opportunity to earn an additional two Prescribed credits for participation in each Translation to Practice^®exercise. Information on Translation to Practice^®will be shared within the activity.

Substance Use Disorders Edition 2

Online CME

15.75 AAFP
Prescribed Credits

Access Through
March 19, 2027

Sessions With Speakers

Speakers

Learning Objectives

System Requirements

CME Credit Statement

Resources You May Also Like

Already Purchased This Activity?

Substance Use Disorders Edition 2

Online CME

15.75 AAFP Prescribed Credits

Access Through March 19, 2027

Sessions With Speakers

Speakers

Learning Objectives

System Requirements

CME Credit Statement

Resources You May Also Like

Already Purchased This Activity?

15.75 AAFP
Prescribed Credits

Access Through
March 19, 2027